Heartsciences' ai-ecg algorithms assigned cms medicare and medicaid reimbursement

Southlake, tx, nov. 13, 2024 (globe newswire) -- heart test laboratories, inc. d/b/a heartsciences (nasdaq: hscs; hscsw) (“heartsciences” or the “company”), an artificial intelligence (ai)-powered medical technology company focused on transforming ecgs/ekgs to save lives through earlier detection of heart disease, today announced that the centers for medicare & medicaid services (cms) has included ai-ecg technology in the 2025 hospital outpatient prospective payment system (opps) final rule under assignment apc 5734. this approval would allow outpatient settings to receive reimbursement for heartsciences' myovista® wavecgtm algorithm and myovista® insightstm low ejection fraction algorithm, upon fda clearance. the payment rate is expected to be $125.
HSCS Ratings Summary
HSCS Quant Ranking